BioStock: Cereno Scientific enters collaboration with University of Michigan
Cereno Scientific, who develops drugs for epigenetic modulation of cardiovascular and rare diseases, just announced a scientific collaboration with the University of Michigan. The agreement covers preclinical studies with compounds from Cereno Scientifics HDACi development program to be performed by Dr Michael Holinstat, who is active at the University and an expert on heamatology and coagulation.
Read the full article at biostock.se:
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se